 | • レポートコード：GIR-105X18309 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、サフリス（アセナピン）のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。サフリス（アセナピン）の種類別市場規模（5mg、10mg）、用途別市場規模（統合失調症、急性躁病、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・サフリス（アセナピン）の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Allergan plc (AbbVie Inc.)、Merck & Co., Inc.、Actavis Generics (Teva) ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：5mg、10mg ・用途別分析2016年-2026年：統合失調症、急性躁病、その他 ・サフリス（アセナピン）の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・サフリス（アセナピン）のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・サフリス（アセナピン）のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・サフリス（アセナピン）の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・サフリス（アセナピン）の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Saphris (Asenapine) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Saphris (Asenapine) size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Saphris (Asenapine) market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Saphris (Asenapine) market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
5 mg
10 mg
Market segment by Application can be divided into
Schizophrenia
Acute Mania
Others
The key market players for global Saphris (Asenapine) market are listed below:
Allergan plc (AbbVie Inc.)
Merck & Co., Inc.
Actavis Generics (Teva)
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Saphris (Asenapine) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Saphris (Asenapine) Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 5 mg
1.2.3 10 mg
1.3 Market Analysis by Application
1.3.1 Overview: Global Saphris (Asenapine) Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Schizophrenia
1.3.3 Acute Mania
1.3.4 Others
1.4 Global Saphris (Asenapine) Market Size & Forecast
1.4.1 Global Saphris (Asenapine) Sales in Value (2016-2026))
1.4.2 Global Saphris (Asenapine) Sales in Volume (2016-2026)
1.4.3 Global Saphris (Asenapine) Price by Type (2016-2026) & (US$/Unit)
1.5 Global Saphris (Asenapine) Production Capacity Analysis
1.5.1 Global Saphris (Asenapine) Total Production Capacity (2016-2026)
1.5.2 Global Saphris (Asenapine) Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Saphris (Asenapine) Market Drivers
1.6.2 Saphris (Asenapine) Market Restraints
1.6.3 Saphris (Asenapine) Trends Analysis
2 Manufacturers Profiles
2.1 Allergan plc (AbbVie Inc.)
2.1.1 Allergan plc (AbbVie Inc.) Details
2.1.2 Allergan plc (AbbVie Inc.) Major Business
2.1.3 Allergan plc (AbbVie Inc.) Saphris (Asenapine) Product and Services
2.1.4 Allergan plc (AbbVie Inc.) Saphris (Asenapine) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Merck & Co., Inc.
2.2.1 Merck & Co., Inc. Details
2.2.2 Merck & Co., Inc. Major Business
2.2.3 Merck & Co., Inc. Saphris (Asenapine) Product and Services
2.2.4 Merck & Co., Inc. Saphris (Asenapine) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Actavis Generics (Teva)
2.3.1 Actavis Generics (Teva) Details
2.3.2 Actavis Generics (Teva) Major Business
2.3.3 Actavis Generics (Teva) Saphris (Asenapine) Product and Services
2.3.4 Actavis Generics (Teva) Saphris (Asenapine) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Saphris (Asenapine) Sales by Manufacturer
3.1 Global Saphris (Asenapine) Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Saphris (Asenapine) Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Saphris (Asenapine)
3.4 Market Concentration Rate
3.4.1 Top 3 Saphris (Asenapine) Manufacturer Market Share
3.4.2 Top 6 Saphris (Asenapine) Manufacturer Market Share
3.5 Global Saphris (Asenapine) Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Saphris (Asenapine) Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Saphris (Asenapine) Market Size by Region
4.1.1 Global Saphris (Asenapine) Sales in Volume by Region (2016-2026)
4.1.2 Global Saphris (Asenapine) Revenue by Region (2016-2026)
4.2 North America Saphris (Asenapine) Revenue (2016-2026)
4.3 Europe Saphris (Asenapine) Revenue (2016-2026)
4.4 Asia-Pacific Saphris (Asenapine) Revenue (2016-2026)
4.5 South America Saphris (Asenapine) Revenue (2016-2026)
4.6 Middle East and Africa Saphris (Asenapine) Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Saphris (Asenapine) Sales in Volume by Type (2016-2026)
5.2 Global Saphris (Asenapine) Revenue by Type (2016-2026)
5.3 Global Saphris (Asenapine) Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Saphris (Asenapine) Sales in Volume by Application (2016-2026)
6.2 Global Saphris (Asenapine) Revenue by Application (2016-2026)
6.3 Global Saphris (Asenapine) Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Saphris (Asenapine) Sales by Type (2016-2026)
7.2 North America Saphris (Asenapine) Sales by Application (2016-2026)
7.3 North America Saphris (Asenapine) Market Size by Country
7.3.1 North America Saphris (Asenapine) Sales in Volume by Country (2016-2026)
7.3.2 North America Saphris (Asenapine) Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Saphris (Asenapine) Sales by Type (2016-2026)
8.2 Europe Saphris (Asenapine) Sales by Application (2016-2026)
8.3 Europe Saphris (Asenapine) Market Size by Country
8.3.1 Europe Saphris (Asenapine) Sales in Volume by Country (2016-2026)
8.3.2 Europe Saphris (Asenapine) Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Saphris (Asenapine) Sales by Type (2016-2026)
9.2 Asia-Pacific Saphris (Asenapine) Sales by Application (2016-2026)
9.3 Asia-Pacific Saphris (Asenapine) Market Size by Region
9.3.1 Asia-Pacific Saphris (Asenapine) Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Saphris (Asenapine) Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Saphris (Asenapine) Sales by Type (2016-2026)
10.2 South America Saphris (Asenapine) Sales by Application (2016-2026)
10.3 South America Saphris (Asenapine) Market Size by Country
10.3.1 South America Saphris (Asenapine) Sales in Volume by Country (2016-2026)
10.3.2 South America Saphris (Asenapine) Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Saphris (Asenapine) Sales by Type (2016-2026)
11.2 Middle East & Africa Saphris (Asenapine) Sales by Application (2016-2026)
11.3 Middle East & Africa Saphris (Asenapine) Market Size by Country
11.3.1 Middle East & Africa Saphris (Asenapine) Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Saphris (Asenapine) Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Saphris (Asenapine) Typical Distributors
12.3 Saphris (Asenapine) Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Saphris (Asenapine) Revenue by Type, (USD Million), 2021-2026
Table 2. Global Saphris (Asenapine) Revenue by Application, (USD Million), 2021-2026
Table 3. Allergan plc (AbbVie Inc.) Basic Information, Manufacturing Base and Competitors
Table 4. Allergan plc (AbbVie Inc.) Major Business
Table 5. Allergan plc (AbbVie Inc.) Saphris (Asenapine) Product and Services
Table 6. Allergan plc (AbbVie Inc.) Saphris (Asenapine) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table 8. Merck & Co., Inc. Major Business
Table 9. Merck & Co., Inc. Saphris (Asenapine) Product and Services
Table 10. Merck & Co., Inc. Saphris (Asenapine) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Actavis Generics (Teva) Basic Information, Manufacturing Base and Competitors
Table 12. Actavis Generics (Teva) Major Business
Table 13. Actavis Generics (Teva) Saphris (Asenapine) Product and Services
Table 14. Actavis Generics (Teva) Saphris (Asenapine) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Global Saphris (Asenapine) Sales by Manufacturer (2019-2021e) & (K Units)
Table 16. Global Saphris (Asenapine) Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 17. Market Position of Manufacturers in Saphris (Asenapine), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 18. Global Saphris (Asenapine) Production Capacity by Company, (K Units): 2020 VS 2021
Table 19. Head Office and Saphris (Asenapine) Production Site of Key Manufacturer
Table 20. Global Saphris (Asenapine) Sales by Region (2016-2021e) & (K Units)
Table 21. Global Saphris (Asenapine) Sales by Region (2021-2026) & (K Units)
Table 22. Global Saphris (Asenapine) Revenue by Region (2016-2021e) & (USD Million)
Table 23. Global Saphris (Asenapine) Revenue by Region (2021-2026) & (USD Million)
Table 24. Global Saphris (Asenapine) Sales by Type (2016-2021e) & (K Units)
Table 25. Global Saphris (Asenapine) Sales by Type (2021-2026) & (K Units)
Table 26. Global Saphris (Asenapine) Revenue by Type (2016-2021e) & (USD Million)
Table 27. Global Saphris (Asenapine) Revenue by Type (2021-2026) & (USD Million)
Table 28. Global Saphris (Asenapine) Price by Type (2016-2021e) & (US$/Unit)
Table 29. Global Saphris (Asenapine) Price by Type (2021-2026) & (US$/Unit)
Table 30. Global Saphris (Asenapine) Sales by Application (2016-2021e) & (K Units)
Table 31. Global Saphris (Asenapine) Sales by Application (2021-2026) & (K Units)
Table 32. Global Saphris (Asenapine) Revenue by Application (2016-2021e) & (USD Million)
Table 33. Global Saphris (Asenapine) Revenue by Application (2021-2026) & (USD Million)
Table 34. Global Saphris (Asenapine) Price by Application (2016-2021e) & (US$/Unit)
Table 35. Global Saphris (Asenapine) Price by Application (2021-2026) & (US$/Unit)
Table 36. North America Saphris (Asenapine) Sales by Country (2016-2021e) & (K Units)
Table 37. North America Saphris (Asenapine) Sales by Country (2021-2026) & (K Units)
Table 38. North America Saphris (Asenapine) Revenue by Country (2016-2021e) & (USD Million)
Table 39. North America Saphris (Asenapine) Revenue by Country (2021-2026) & (USD Million)
Table 40. North America Saphris (Asenapine) Sales by Type (2016-2021e) & (K Units)
Table 41. North America Saphris (Asenapine) Sales by Type (2021-2026) & (K Units)
Table 42. North America Saphris (Asenapine) Sales by Application (2016-2021e) & (K Units)
Table 43. North America Saphris (Asenapine) Sales by Application (2021-2026) & (K Units)
Table 44. Europe Saphris (Asenapine) Sales by Country (2016-2021e) & (K Units)
Table 45. Europe Saphris (Asenapine) Sales by Country (2021-2026) & (K Units)
Table 46. Europe Saphris (Asenapine) Revenue by Country (2016-2021e) & (USD Million)
Table 47. Europe Saphris (Asenapine) Revenue by Country (2021-2026) & (USD Million)
Table 48. Europe Saphris (Asenapine) Sales by Type (2016-2021e) & (K Units)
Table 49. Europe Saphris (Asenapine) Sales by Type (2021-2026) & (K Units)
Table 50. Europe Saphris (Asenapine) Sales by Application (2016-2021e) & (K Units)
Table 51. Europe Saphris (Asenapine) Sales by Application (2021-2026) & (K Units)
Table 52. Asia-Pacific Saphris (Asenapine) Sales by Region (2016-2021e) & (K Units)
Table 53. Asia-Pacific Saphris (Asenapine) Sales by Region (2021-2026) & (K Units)
Table 54. Asia-Pacific Saphris (Asenapine) Revenue by Region (2016-2021e) & (USD Million)
Table 55. Asia-Pacific Saphris (Asenapine) Revenue by Region (2021-2026) & (USD Million)
Table 56. Asia-Pacific Saphris (Asenapine) Sales by Type (2016-2021e) & (K Units)
Table 57. Asia-Pacific Saphris (Asenapine) Sales by Type (2021-2026) & (K Units)
Table 58. Asia-Pacific Saphris (Asenapine) Sales by Application (2016-2021e) & (K Units)
Table 59. Asia-Pacific Saphris (Asenapine) Sales by Application (2021-2026) & (K Units)
Table 60. South America Saphris (Asenapine) Sales by Country (2016-2021e) & (K Units)
Table 61. South America Saphris (Asenapine) Sales by Country (2021-2026) & (K Units)
Table 62. South America Saphris (Asenapine) Revenue by Country (2016-2021e) & (USD Million)
Table 63. South America Saphris (Asenapine) Revenue by Country (2021-2026) & (USD Million)
Table 64. South America Saphris (Asenapine) Sales by Type (2016-2021e) & (K Units)
Table 65. South America Saphris (Asenapine) Sales by Type (2021-2026) & (K Units)
Table 66. South America Saphris (Asenapine) Sales by Application (2016-2021e) & (K Units)
Table 67. South America Saphris (Asenapine) Sales by Application (2021-2026) & (K Units)
Table 68. Middle East & Africa Saphris (Asenapine) Sales by Country (2016-2021e) & (K Units)
Table 69. Middle East & Africa Saphris (Asenapine) Sales by Country (2021-2026) & (K Units)
Table 70. Middle East & Africa Saphris (Asenapine) Revenue by Country (2016-2021e) & (USD Million)
Table 71. Middle East & Africa Saphris (Asenapine) Revenue by Country (2021-2026) & (USD Million)
Table 72. Middle East & Africa Saphris (Asenapine) Sales by Type (2016-2021e) & (K Units)
Table 73. Middle East & Africa Saphris (Asenapine) Sales by Type (2021-2026) & (K Units)
Table 74. Middle East & Africa Saphris (Asenapine) Sales by Application (2016-2021e) & (K Units)
Table 75. Middle East & Africa Saphris (Asenapine) Sales by Application (2021-2026) & (K Units)
Table 76. Direct Channel Pros & Cons
Table 77. Indirect Channel Pros & Cons
Table 78. Saphris (Asenapine) Typical Distributors
Table 79. Saphris (Asenapine) Typical Customers
List of Figures
Figure 1. Saphris (Asenapine) Picture
Figure 2. Global Saphris (Asenapine) Sales Market Share by Type in 2020
Figure 3. 5 mg
Figure 4. 10 mg
Figure 5. Global Saphris (Asenapine) Sales Market Share by Application in 2020
Figure 6. Schizophrenia
Figure 7. Acute Mania
Figure 8. Others
Figure 9. Global Saphris (Asenapine) Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 10. Global Saphris (Asenapine) Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. United States Saphris (Asenapine) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Canada Saphris (Asenapine) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Mexico Saphris (Asenapine) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Germany Saphris (Asenapine) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. France Saphris (Asenapine) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. United Kingdom Saphris (Asenapine) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Russia Saphris (Asenapine) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Italy Saphris (Asenapine) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. China Saphris (Asenapine) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Japan Saphris (Asenapine) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Korea Saphris (Asenapine) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. India Saphris (Asenapine) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Southeast Asia Saphris (Asenapine) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Australia Saphris (Asenapine) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Brazil Saphris (Asenapine) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Egypt Saphris (Asenapine) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Saudi Arabia Saphris (Asenapine) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. South Africa Saphris (Asenapine) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Turkey Saphris (Asenapine) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Global Saphris (Asenapine) Sales (2016-2026) & (K Units)
Figure 31. Global Saphris (Asenapine) Production Capacity (2016-2026) & (K Units)
Figure 32. Global Saphris (Asenapine) Production Capacity by Geographic Region: 2020 VS 2021
Figure 33. Saphris (Asenapine) Market Drivers
Figure 34. Saphris (Asenapine) Market Restraints
Figure 35. Saphris (Asenapine) Market Trends
Figure 36. Global Saphris (Asenapine) Sales Market Share by Manufacturer in 2020
Figure 37. Global Saphris (Asenapine) Revenue Market Share by Manufacturer in 2020
Figure 38. Saphris (Asenapine) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 39. Top 3 Saphris (Asenapine) Manufacturer (Revenue) Market Share in 2020
Figure 40. Top 6 Saphris (Asenapine) Manufacturer (Revenue) Market Share in 2020
Figure 41. Global Saphris (Asenapine) Sales Market Share by Region (2016-2026)
Figure 42. Global Saphris (Asenapine) Revenue Market Share by Region (2016-2026)
Figure 43. North America Saphris (Asenapine) Revenue (2016-2026) & (USD Million)
Figure 44. Europe Saphris (Asenapine) Revenue (2016-2026) & (USD Million)
Figure 45. Asia-Pacific Saphris (Asenapine) Revenue (2016-2026) & (USD Million)
Figure 46. South America Saphris (Asenapine) Revenue (2016-2026) & (USD Million)
Figure 47. Middle East & Africa Saphris (Asenapine) Revenue (2016-2026) & (USD Million)
Figure 48. Global Saphris (Asenapine) Sales Market Share by Type (2016-2026)
Figure 49. Global Saphris (Asenapine) Revenue Market Share by Type (2016-2026)
Figure 50. Global Saphris (Asenapine) Price by Type (2016-2026) & (US$/Unit)
Figure 51. Global Saphris (Asenapine) Sales Market Share by Application (2016-2026)
Figure 52. Global Saphris (Asenapine) Revenue Market Share by Application (2016-2026)
Figure 53. Global Saphris (Asenapine) Price by Application (2016-2026) & (US$/Unit)
Figure 54. North America Saphris (Asenapine) Sales Market Share by Country (2016-2026)
Figure 55. North America Saphris (Asenapine) Revenue Market Share by Country (2016-2026)
Figure 56. North America Saphris (Asenapine) Sales Market Share by Type (2016-2026)
Figure 57. North America Saphris (Asenapine) Sales Market Share by Application (2016-2026)
Figure 58. Europe Saphris (Asenapine) Sales Market Share by Country (2016-2026)
Figure 59. Europe Saphris (Asenapine) Revenue Market Share by Country (2016-2026)
Figure 60. Europe Saphris (Asenapine) Sales Market Share by Type (2016-2026)
Figure 61. Europe Saphris (Asenapine) Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Saphris (Asenapine) Sales Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Saphris (Asenapine) Revenue Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Saphris (Asenapine) Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Saphris (Asenapine) Sales Market Share by Application (2016-2026)
Figure 66. South America Saphris (Asenapine) Sales Market Share by Country (2016-2026)
Figure 67. South America Saphris (Asenapine) Revenue Market Share by Country (2016-2026)
Figure 68. South America Saphris (Asenapine) Sales Market Share by Type (2016-2026)
Figure 69. South America Saphris (Asenapine) Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Saphris (Asenapine) Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Saphris (Asenapine) Revenue Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Saphris (Asenapine) Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Saphris (Asenapine) Sales Market Share by Application (2016-2026)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
Figure 75. Methodology
Figure 76. Research Process and Data Source
統合失調症治療薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Schizophrenia therapeutics are used as a standard treatment regimen for schizophrenia. It helps in reversing the low levels of dopamine and serotonin, thereby improving the patient's condition. Scope of the Report: This report studies the Schizophrenia Therapeutics market status and outlook of Globa…- 急性間欠性ポルフィリン症薬の世界市場2018-2025 Acute intermittent porphyria (AIP), also called Swedish porphyria, pyrroloporphyria, intermittent acute porphyria) is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen deaminase. It is the most common of the acute porphyr…
- 急性間欠性ポルフィリン症トリートメントの世界市場2018-2025 Acute intermittent porphyria (AIP), also called Swedish porphyria, pyrroloporphyria, intermittent acute porphyria) is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen deaminase. It is the most common of the acute porphyr…
- 急性間欠性ポルフィリン症治療の世界市場2018-2025 Acute intermittent porphyria (AIP), also called Swedish porphyria, pyrroloporphyria, intermittent acute porphyria) is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen deaminase. It is the most common of the acute porphyr…
- 世界の急性虚血モニター市場 2021：企業別、地域別、種類・用途別 The Acute Ischemia Monitors market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…